[1]
Wallace, MD, M.S., Moulin, MD, D., Clark, FRCPC, A.J.M., Wasserman, MD, R., Neale, A., Morley-Forster, MD, P., Castaigne, MD, J.-P. and Teichman, MD, S. 2006. A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008—a long-acting, parenteral opioid analgesic—in the treatment of postherpetic neuralgia. Journal of Opioid Management. 2, 3 (May 2006), 167–173. DOI:https://doi.org/10.5055/jom.2006.0026.